FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

386999001: Poractant alfa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1461177011 Poractant alfa (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1481113011 Poractant alfa en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Poractant alfa Is a Lung surfactant true Inferred relationship Existential restriction modifier
Poractant alfa Is a Drug allergen false Inferred relationship Existential restriction modifier
Poractant alfa Has disposition Surfactant true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing poractant alfa Has active ingredient True Poractant alfa Inferred relationship Existential restriction modifier 1
Phospholipid fraction allergy Causative agent False Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 120mg/1.5mL sterile suspension Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 240mg/3mL sterile suspension Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 80mg/mL suspension Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Phospholipid fraction adverse reaction Causative agent False Poractant alfa Inferred relationship Existential restriction modifier 1
Phospholipid fraction allergy Causative agent False Poractant alfa Inferred relationship Existential restriction modifier 1
Product containing precisely phospholipid (as poractant alfa) 240 milligram/3 milliliter conventional release suspension for endotracheopulmonary instillation vial Has precise active ingredient False Poractant alfa Inferred relationship Existential restriction modifier 1
Product containing precisely phospholipid (as poractant alfa) 120 milligram/1.5 milliliter conventional release suspension for endotracheopulmonary instillation vial Has precise active ingredient False Poractant alfa Inferred relationship Existential restriction modifier 1
Product containing poractant alfa in pulmonary dose form (medicinal product form) Has active ingredient True Poractant alfa Inferred relationship Existential restriction modifier 1
Poractant alfa Has active ingredient True Poractant alfa Inferred relationship Existential restriction modifier 1
Product containing only poractant alfa in pulmonary dose form (medicinal product form) Has active ingredient True Poractant alfa Inferred relationship Existential restriction modifier 1
Product containing precisely poractant alfa 80 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) Has precise active ingredient True Poractant alfa Inferred relationship Existential restriction modifier 1
Product containing precisely poractant alfa 80 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) Has basis of strength substance True Poractant alfa Inferred relationship Existential restriction modifier 1
Adverse reaction to poractant alfa Causative agent True Poractant alfa Inferred relationship Existential restriction modifier 1
Poractant alfa 120mg/1.5mL sterile suspension - product Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 240mg/3mL sterile suspension - product Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Curosurf 240mg/3mL sterile suspension Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Curosurf 120mg/1.5mL sterile suspension Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Curosurf 240mg/3ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) Has active ingredient True Poractant alfa Inferred relationship Existential restriction modifier
Curosurf 120mg/1.5ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) Has active ingredient True Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 240mg/3ml endotracheopulmonary suspension vials 1 vial Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 120mg/1.5ml endotracheopulmonary suspension vials 1 vial Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Curosurf 240mg/3ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) 1 vial Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Curosurf 120mg/1.5ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) 1 vial Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 120mg/1.5mL sterile suspension Has specific active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Curosurf 120mg/1.5ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Poractant alfa Inferred relationship Existential restriction modifier
Curosurf 120mg/1.5ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) Has specific active ingredient True Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 120mg/1.5ml endotracheopulmonary suspension vials 1 vial Has specific active ingredient True Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 240mg/3mL sterile suspension Has specific active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Curosurf 240mg/3ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) Has specific active ingredient True Poractant alfa Inferred relationship Existential restriction modifier
Curosurf 240mg/3ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 240mg/3ml endotracheopulmonary suspension vials 1 vial Has specific active ingredient True Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 120mg/1.5ml endotracheopulmonary suspension vials Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 240mg/3ml endotracheopulmonary suspension vials Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 120mg/1.5ml endotracheopulmonary suspension vials Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 120mg/1.5ml endotracheopulmonary suspension vials Has specific active ingredient True Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 240mg/3ml endotracheopulmonary suspension vials Has active ingredient False Poractant alfa Inferred relationship Existential restriction modifier
Poractant alfa 240mg/3ml endotracheopulmonary suspension vials Has specific active ingredient True Poractant alfa Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start